Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
    • AGM Invitations
    • IPOs
  • inderesTV
  • Forum
  • Discovery
  • About Us
    • Our Coverage
    • Team

AlzeCure Pharma

1.48 SEK

+5.71 %

Less than 1K followers

ALZCUR

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data

Income statement

Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for AlzeCure Pharma

2019202020212022202320242025
Revenue
growth-%
EBITDA-50.6-71.1-77.4-55.9-37.8-36.1-46.6
EBIT-50.9-71.6-77.9-56.4-38.3-36.1-47.9
Profit before taxes-50.9-71.4-77.8-56.2-37.2-35.2-47.7
Net income-50.9-71.4-77.8-56.2-37.2-35.2-47.7
EPS-1.16-1.63-1.77-1.06-0.54-0.44-0.47
Dividend0.000.000.000.000.000.000.00
Dividend ratio-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %-0.0 %

Profitability and return on capital

2019202020212022202320242025
EBITDA-%
EBIT-%
ROE-27.9 %-64.4 %-235.9 %-93.0 %-156.4 %-134.5 %-144.8 %
ROI-27.2 %-60.6 %-170.4 %-79.4 %-116.2 %-102.3 %-80.7 %
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.